Skyhawk Therapeutics

Skyhawk Therapeutics

We Use Small Molecules To Modify RNA Splicing

Location
Roles tracked
0
In pipeline
0
Tracking since

At a glance

You're tracking 0 roles at Skyhawk Therapeutics. Track a role to start building momentum here.

Company intel

From the job board · LinkedIn data via posting sync
Industry
Biotechnology Research
Company size
88 people
Headquarters
Waltham, Massachusetts
Founded
2016
Type
Privately Held
Total funding
$181.2M

Skyhawk Therapeutics is a drug discovery and development company focused on revolutionizing disease treatment with small molecules that modify RNA expression. Our founders are leading experts in small molecule therapeutics development for RNA-based disease. Our first drug candidates are targeted toward cancers and neurological conditions. The company is based in Waltham, Massachusetts. For more information, please visit: www.skyhawktx.com.

Biotechnology Therapeutics

Open roles at Skyhawk Therapeutics